Granahan Investment Management, LLC Veracyte, Inc. Transaction History

Granahan Investment Management, LLC

$2.78 Billion
Q1 2024

A detailed history of Granahan Investment Management, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Granahan Investment Management, LLC holds 342,264 shares of VCYT stock, worth $7.1 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

342,264

Previous 503,898 32.08%

Holding current value

$7.1 Million

Previous $13.9 Million 45.29%

% of portfolio

0.27%

Previous 0.46%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$21.0 - $29.1 $3.39 Million - $4.7 Million	-161,634 Reduced 32.08%	342,264 $7.58 Million
Q4 2023 Feb 14, 2024	BUY	$19.72 - $28.68 $2.42 Million - $3.52 Million	122,574 Added 32.14%	503,898 $13.9 Million
Q3 2023 Nov 14, 2023	SELL	$22.33 - $29.92 $4.7 Million - $6.29 Million	-210,358 Reduced 35.55%	381,324 $8.51 Million
Q2 2023 Aug 14, 2023	SELL	$20.96 - $26.99 $11.6 Million - $14.9 Million	-553,845 Reduced 48.35%	591,682 $15.1 Million
Q1 2023 May 15, 2023	SELL	$20.58 - $27.89 $12.7 Million - $17.2 Million	-617,739 Reduced 35.03%	1,145,527 $25.5 Million

Q4 2022 Feb 14, 2023	SELL	$15.31 - $29.94 $2.42 Million - $4.74 Million	-158,240 Reduced 8.24%	1,763,266 $41.8 Million
Q3 2022 Nov 14, 2022	SELL	$16.58 - $27.9 $422,740 - $711,366	-25,497 Reduced 1.31%	1,921,506 $31.9 Million
Q2 2022 Aug 15, 2022	SELL	$15.45 - $29.52 $212,174 - $405,398	-13,733 Reduced 0.7%	1,947,003 $38.7 Million
Q1 2022 May 16, 2022	BUY	$21.94 - $42.51 $3.65 Million - $7.07 Million	166,341 Added 9.27%	1,960,736 $54.1 Million
Q4 2021 Feb 14, 2022	BUY	$36.09 - $53.79 $2.19 Million - $3.26 Million	60,694 Added 3.5%	1,794,395 $73.9 Million
Q3 2021 Nov 15, 2021	SELL	$35.62 - $52.97 $797,033 - $1.19 Million	-22,376 Reduced 1.27%	1,733,701 $80.5 Million
Q2 2021 Aug 16, 2021	BUY	$32.94 - $56.62 $23 Million - $39.5 Million	697,340 Added 65.87%	1,756,077 $70.2 Million
Q1 2021 May 17, 2021	BUY	$44.47 - $81.38 $23 Million - $42.1 Million	517,624 Added 95.66%	1,058,737 $56.9 Million
Q4 2020 Feb 12, 2021	SELL	$32.49 - $61.88 $6.31 Million - $12 Million	-194,189 Reduced 26.41%	541,113 $26.5 Million
Q3 2020 Nov 12, 2020	BUY	$26.73 - $35.67 $3.28 Million - $4.37 Million	122,549 Added 20.0%	735,302 $23.9 Million
Q2 2020 Aug 14, 2020	BUY	$19.49 - $28.11 $3.49 Million - $5.03 Million	179,114 Added 41.3%	612,753 $15.9 Million
Q1 2020 May 12, 2020	BUY	$16.13 - $30.17 $833,630 - $1.56 Million	51,682 Added 13.53%	433,639 $10.5 Million
Q4 2019 Feb 14, 2020	BUY	$20.78 - $29.99 $5.13 Million - $7.4 Million	246,907 Added 182.83%	381,957 $10.7 Million
Q3 2019 Nov 15, 2019	BUY	$23.87 - $30.93 $879,752 - $1.14 Million	36,856 Added 37.53%	135,050 $3.24 Million
Q2 2019 Aug 14, 2019	BUY	$22.1 - $28.56 $2.17 Million - $2.8 Million	98,194 New	98,194 $2.8 Million

Others Institutions Holding VCYT

# of Institutions

257

Shares Held

81.7M

Call Options Held

43K

Put Options Held

82K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $1.49B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granahan Investment Management, LLC with notifications on news.

Account

Granahan Investment Management, LLC Veracyte, Inc. Transaction History